SansRosa Pharmaceutical Development

PharmaceuticalsSeedUS

Latest round

Seed

Last raised

Jan 2004

Total raised

$0.5M

Investors

1

About SansRosa Pharmaceutical Development

Based in the United States, SansRosa Pharmaceutical Development, Inc. researches and develops dermatological products for the treatment of rosacea, a long-term skin condition that primarily affects the facial region.

Who invested in SansRosa Pharmaceutical Development

1 investor across 1 round

See all investors in SansRosa Pharmaceutical Development

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jan 25, 2004

    Amount

    $0.5M

    Investors

    Locked

Questions about SansRosa Pharmaceutical Development

Who invested in SansRosa Pharmaceutical Development?

SansRosa Pharmaceutical Development has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has SansRosa Pharmaceutical Development raised?

SansRosa Pharmaceutical Development has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did SansRosa Pharmaceutical Development last raise money?

SansRosa Pharmaceutical Development's most recent round on record is a Seed, in Jan 2004.

What does SansRosa Pharmaceutical Development do?

Based in the United States, SansRosa Pharmaceutical Development, Inc.

Where is SansRosa Pharmaceutical Development headquartered?

SansRosa Pharmaceutical Development is headquartered in US.

Which VCs invest in companies like SansRosa Pharmaceutical Development?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at SansRosa Pharmaceutical Development's stage. Their profiles are linked below.

Raising like SansRosa Pharmaceutical Development? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.